A detailed history of Liberty Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Liberty Wealth Management LLC holds 7,172 shares of ABBV stock, worth $1.44 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,172
Previous 11,641 38.39%
Holding current value
$1.44 Million
Previous $1.24 Million 14.56%
% of portfolio
0.25%
Previous 0.23%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$163.84 - $199.33 $732,200 - $890,805
-4,469 Reduced 38.39%
7,172 $1.42 Million
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $748,100 - $873,613
4,833 Added 70.99%
11,641 $1.24 Million
Q1 2024

May 02, 2024

SELL
$159.82 - $182.1 $57,854 - $65,920
-362 Reduced 5.05%
6,808 $1.24 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $13,484 - $15,187
98 Added 1.39%
7,170 $1.11 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $3,339 - $3,866
25 Added 0.35%
7,072 $1.05 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $5,300 - $6,596
-40 Reduced 0.56%
7,047 $949,000
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $8,098 - $9,326
56 Added 0.8%
7,087 $1.13 Million
Q3 2022

Nov 15, 2022

SELL
$134.21 - $153.93 $285,733 - $327,716
-2,129 Reduced 23.24%
7,031 $943,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $50,919 - $64,735
370 Added 4.21%
9,160 $1.32 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $122,477 - $151,960
-928 Reduced 9.55%
8,790 $1.42 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $39,641 - $50,158
-369 Reduced 3.66%
9,718 $1.32 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $236,101 - $268,010
2,219 Added 28.2%
10,087 $1.11 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $92.4 Million - $103 Million
-878,334 Reduced 99.11%
7,868 $886,000
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $92.5 Million - $103 Million
878,991 Added 12189.59%
886,202 $7.87 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $135,464 - $182,891
1,683 Added 30.45%
7,211 $737,000
Q3 2020

Nov 05, 2020

BUY
$85.91 - $100.83 $60,652 - $71,185
706 Added 14.64%
5,528 $484,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $177,848 - $237,988
2,424 Added 101.08%
4,822 $475,000
Q1 2020

Apr 27, 2020

BUY
$64.5 - $97.79 $12,513 - $18,971
194 Added 8.8%
2,398 $183,000
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $57,415 - $71,839
796 Added 56.53%
2,204 $195,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $37,158 - $44,674
-590 Reduced 29.53%
1,408 $107,000
Q2 2019

Jul 30, 2019

BUY
$65.7 - $83.98 $48,026 - $61,389
731 Added 57.7%
1,998 $145,000
Q1 2019

Apr 18, 2019

SELL
$77.14 - $90.79 $948,436 - $1.12 Million
-12,295 Reduced 90.66%
1,267 $102,000
Q4 2018

Mar 26, 2019

BUY
$77.85 - $96.01 $1.06 Million - $1.3 Million
13,562 New
13,562 $1.25 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Liberty Wealth Management LLC Portfolio

Follow Liberty Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty Wealth Management LLC with notifications on news.